TL;DR: B vitamins are not a single nutrient but a family of eight water-soluble compounds, several of which are critically important for brain function. B12 (cobalamin), B9 (folate), and B6 (pyridoxine) work together to regulate homocysteine — an amino acid that, when elevated, is strongly associated with cognitive decline and brain atrophy. B1 (thiamine) and B3 (niacin) play essential roles in brain energy metabolism. Deficiency in B12 or folate can cause irreversible neurological damage. The landmark VITACOG trial showed that high-dose B vitamin supplementation slowed brain atrophy by 30 percent in older adults with elevated homocysteine. Vegans, older adults, metformin users, and those on proton pump inhibitors are at highest risk. Food-first strategies should be the foundation, but targeted supplementation is warranted for at-risk populations.
Introduction
The B vitamins are a group of eight chemically distinct water-soluble nutrients that share a common thread: they are essential cofactors in hundreds of metabolic reactions, many of which are disproportionately important in the brain. The brain accounts for roughly 2 percent of body weight but consumes approximately 20 percent of the body’s total energy and oxygen. This extraordinary metabolic demand makes the brain exquisitely sensitive to shortfalls in the nutrients that keep its biochemistry running — and B vitamins sit at the center of that biochemistry.
Among the eight B vitamins, five deserve particular attention for their roles in cognitive function: B1 (thiamine), B3 (niacin), B6 (pyridoxine), B9 (folate), and B12 (cobalamin). These nutrients intersect at a critical metabolic junction known as one-carbon metabolism — the network of biochemical reactions that governs methylation, DNA synthesis, neurotransmitter production, and the regulation of homocysteine, an amino acid whose accumulation is increasingly recognized as both a marker and a mechanistic driver of brain aging.
This is not a marginal concern. Population-level data consistently show that B12 deficiency affects between 6 and 20 percent of adults over 60 in developed countries, with subclinical insufficiency rates substantially higher. Folate inadequacy remains common even in countries with mandatory fortification. And because B vitamin deficiencies develop gradually, neurological damage can progress silently for years before clinical symptoms appear — at which point some of that damage may be irreversible.
This article covers what each key B vitamin does in the brain, how homocysteine connects them all, who is at greatest risk, and what the evidence says about supplementation.
The Key B Vitamins for Brain Health
B1 — Thiamine: The Energy Gatekeeper
Thiamine is a cofactor for three critical enzyme complexes in brain energy metabolism: pyruvate dehydrogenase, alpha-ketoglutarate dehydrogenase, and transketolase. These enzymes sit at chokepoints in glucose metabolism and the citric acid cycle — the pathways that generate the ATP neurons depend on for survival and signaling.
When thiamine is depleted, brain energy production collapses. The clinical result is Wernicke encephalopathy, an acute neurological emergency characterized by confusion, ataxia, and eye movement abnormalities. If untreated, it progresses to Korsakoff syndrome — a devastating condition marked by profound anterograde amnesia and confabulation. While classically associated with chronic alcoholism (which impairs thiamine absorption and increases its excretion), Wernicke-Korsakoff syndrome can also occur in malnutrition, bariatric surgery patients, hyperemesis gravidarum, and anyone with severely restricted food intake.
Beyond these extreme presentations, subclinical thiamine insufficiency may contribute to fatigue, irritability, and impaired concentration — symptoms that are easily attributed to other causes and therefore frequently overlooked.
Key food sources: Pork, whole grains, legumes, seeds (especially sunflower seeds), and fortified cereals.
B3 — Niacin: NAD+ and Beyond
Niacin (vitamin B3) is the precursor to nicotinamide adenine dinucleotide (NAD+), one of the most important coenzymes in human biology. NAD+ participates in over 400 enzymatic reactions, including mitochondrial energy production, DNA repair, and the activity of sirtuins — a family of enzymes that regulate cellular stress responses, inflammation, and aging.
In the brain, NAD+ is essential for maintaining neuronal energy supply and for activating PARP enzymes that repair DNA damage — a process that accelerates with age. Severe niacin deficiency causes pellagra, whose classical triad of symptoms includes dermatitis, diarrhea, and dementia. The dementia of pellagra reflects widespread neuronal dysfunction and can be fatal if untreated. While frank pellagra is now rare in developed countries thanks to food fortification, there is growing interest in whether age-related NAD+ decline — even without overt niacin deficiency — contributes to neurodegenerative disease.
Key food sources: Poultry, tuna, salmon, beef, mushrooms, peanuts, and fortified grains. The body can also synthesize niacin from the amino acid tryptophan, though this conversion is inefficient.
B6 — Pyridoxine: The Neurotransmitter Builder
Pyridoxal 5’-phosphate (PLP), the active form of vitamin B6, is a cofactor for over 140 enzymatic reactions — more than any other coenzyme. In the brain, its most consequential roles involve neurotransmitter synthesis. B6 is required for the production of serotonin (from tryptophan), dopamine and norepinephrine (from tyrosine), GABA (from glutamate), and histamine (from histidine). Without adequate B6, the brain cannot manufacture these signaling molecules at normal rates.
B6 is also essential for the transsulfuration pathway, where homocysteine is converted to cysteine (a precursor of the antioxidant glutathione). This places B6 alongside folate and B12 as one of the three vitamins directly responsible for keeping homocysteine levels in check.
Deficiency in B6 is associated with depression, confusion, and impaired immune function. A large cross-sectional analysis of NHANES data found that low PLP levels were associated with increased depressive symptoms, independent of other nutritional and demographic factors.
Key food sources: Poultry, fish (especially tuna and salmon), potatoes, chickpeas, bananas, and fortified cereals.
B9 — Folate: The Methylation Workhorse
Folate (vitamin B9) is arguably the most metabolically versatile of the B vitamins. In its active form — 5-methyltetrahydrofolate (5-MTHF) — it serves as the primary methyl donor in the remethylation of homocysteine to methionine, a reaction catalyzed by methionine synthase with B12 as an essential cofactor. Methionine is then converted to S-adenosylmethionine (SAMe), the universal methyl donor used in over 200 methylation reactions including DNA methylation, histone modification, phospholipid synthesis, and neurotransmitter metabolism.
Folate’s role in neural tube development is its most famous public health contribution. The discovery that periconceptional folic acid supplementation dramatically reduces the risk of neural tube defects (NTDs) — including spina bifida and anencephaly — is one of the great successes of nutritional science. The landmark Medical Research Council Vitamin Study (MRC, 1991) demonstrated a 72 percent reduction in NTD recurrence with folic acid supplementation, leading to mandatory folic acid fortification of grain products in the United States and more than 80 other countries.
In adults, folate deficiency causes megaloblastic anemia (indistinguishable from that caused by B12 deficiency), elevated homocysteine, and an increased risk of depression. Low folate status has been consistently associated with poorer cognitive performance in observational studies, particularly in older adults.
Key food sources: Dark leafy greens (spinach, kale, collard greens), legumes (lentils, black beans, chickpeas), asparagus, Brussels sprouts, avocado, and fortified grains.
B12 — Cobalamin: The Nerve Protector
Vitamin B12 is unique among all vitamins in its complexity — it is the largest and most structurally elaborate vitamin molecule, containing a cobalt atom at its center. It participates in only two enzymatic reactions in humans, but both are profoundly important.
First, B12 is a cofactor for methionine synthase, the enzyme that converts homocysteine to methionine using a methyl group donated by folate. Without B12, this reaction stalls — homocysteine accumulates, methionine falls, SAMe production drops, and the entire methylation cascade is disrupted. This also creates a “methyl trap” in which folate becomes locked in its methylated form and unavailable for DNA synthesis, explaining why B12 deficiency causes the same megaloblastic anemia as folate deficiency.
Second, B12 is a cofactor for methylmalonyl-CoA mutase, an enzyme in the mitochondrial breakdown of odd-chain fatty acids and branched-chain amino acids. When this enzyme fails due to B12 deficiency, methylmalonic acid (MMA) accumulates. Elevated MMA is the most sensitive and specific biomarker for functional B12 deficiency and is believed to directly contribute to the neurological damage seen in B12-deficient patients.
The neurological consequences of B12 deficiency are among the most serious of any vitamin deficiency. Subacute combined degeneration of the spinal cord — demyelination of the dorsal and lateral columns — produces progressive numbness, tingling, gait instability, and eventually paralysis if untreated. Cognitive impairment, memory loss, personality changes, and frank dementia can also occur. Critically, neurological damage from B12 deficiency can develop even in the absence of anemia, and once established, may be only partially reversible.
Key food sources: B12 is found exclusively in animal-derived foods — liver, clams, sardines, beef, salmon, eggs, and dairy. There is no reliable plant source of bioactive B12, making supplementation essential for vegans.
Homocysteine: The Unifying Thread
If there is a single concept that ties the B vitamins together in the context of brain health, it is homocysteine. Homocysteine is a sulfur-containing amino acid produced as a normal intermediate in methionine metabolism. It sits at a metabolic crossroads: it can be remethylated back to methionine (requiring folate and B12) or diverted down the transsulfuration pathway to cysteine (requiring B6). When any of these three vitamins is insufficient, homocysteine accumulates.
Elevated homocysteine (hyperhomocysteinemia, generally defined as >12-15 micromol/L) is one of the most consistently replicated risk factors for cognitive decline, brain atrophy, and dementia. The Framingham Offspring Study found that individuals with homocysteine levels above 14 micromol/L had nearly double the risk of developing Alzheimer’s disease over an eight-year follow-up period. The Hordaland Homocysteine Study in Norway demonstrated a strong, graded association between homocysteine levels and poor cognitive performance in over 7,000 elderly subjects.
The mechanism is not merely associational. Elevated homocysteine is directly neurotoxic through multiple pathways: it activates NMDA receptors (causing excitotoxic damage), generates reactive oxygen species, damages cerebrovascular endothelium, impairs DNA repair, and disrupts methylation of myelin basic protein.
The VITACOG Trial
The most compelling interventional evidence comes from the VITACOG trial (Vitamins to Prevent Cognitive Decline and Dementia), conducted by A. David Smith and colleagues at the University of Oxford. Published in 2010 in PLoS ONE, this randomized, double-blind, placebo-controlled trial enrolled 168 older adults (age 70+) with mild cognitive impairment and measured brain atrophy by serial MRI over two years.
Participants receiving high-dose B vitamins (0.8 mg folic acid, 0.5 mg B12, and 20 mg B6 daily) showed a 30 percent reduction in the rate of whole-brain atrophy compared to placebo. Remarkably, in participants who entered the trial with elevated homocysteine (>13 micromol/L), the atrophy rate was reduced by 53 percent. A subsequent analysis by Douaud et al. (2013), published in the Proceedings of the National Academy of Sciences, used region-specific MRI and demonstrated that B vitamin supplementation selectively reduced atrophy in brain regions most vulnerable to Alzheimer’s disease — including the medial temporal lobe.
Critically, the benefit was dose-dependent on baseline homocysteine. Participants with normal homocysteine levels at baseline showed little benefit, while those with elevated levels showed dramatic protection. This suggests that B vitamin supplementation for brain health is most impactful when there is a clear metabolic deficit to correct — it is targeted therapy, not indiscriminate supplementation.
The VITACOG findings also interacted with omega-3 fatty acid status: Jerneren et al. (2015) showed that the B vitamin treatment was effective only in participants with adequate omega-3 levels, suggesting a synergistic relationship between B vitamin-mediated homocysteine lowering and omega-3-dependent neuroprotection.
One-Carbon Metabolism and Methylation
The biochemical network connecting folate, B12, B6, and homocysteine is known as one-carbon metabolism — so named because it involves the transfer of single carbon units (methyl groups) between molecules. This network is one of the most fundamental in human biochemistry, and the brain is particularly dependent on it.
One-carbon metabolism serves several critical functions in the brain. It regenerates SAMe, which is required for methylation of DNA (regulating gene expression), myelin (maintaining nerve insulation), phospholipids (building cell membranes), and neurotransmitters (modulating mood and cognition). It provides the building blocks for DNA and RNA synthesis, essential for any cell that divides — including the neural progenitor cells that continue to generate new neurons in the hippocampus throughout adulthood. And it regulates the pool of homocysteine, preventing its accumulation to neurotoxic levels.
When one-carbon metabolism is disrupted — by deficiency of folate, B12, or B6 — the downstream consequences radiate outward: impaired methylation, impaired nucleotide synthesis, elevated homocysteine, and compromised neurotransmitter production. The brain, with its extraordinary metabolic demands, is among the first organs to suffer.
MTHFR Polymorphisms
A discussion of folate and brain health would be incomplete without addressing the MTHFR gene — specifically, the C677T and A1298C polymorphisms that have generated enormous public interest and, unfortunately, considerable misinformation.
The MTHFR (methylenetetrahydrofolate reductase) enzyme converts 5,10-methylenetetrahydrofolate to 5-methyltetrahydrofolate (5-MTHF), the biologically active form of folate used in the remethylation of homocysteine. The C677T variant produces an enzyme with reduced thermostability and approximately 30 percent lower activity in heterozygotes (CT genotype) and 65 percent lower activity in homozygotes (TT genotype).
The TT genotype is carried by approximately 10 to 15 percent of North American and European populations, with higher prevalence in certain ethnic groups (up to 25 percent in some Hispanic and Italian populations). Individuals with this genotype tend to have higher homocysteine levels, particularly when folate intake is inadequate. The combination of the TT genotype and low folate status has been associated with increased risk for neural tube defects, cardiovascular disease, depression, and cognitive decline in observational studies.
However, this does not mean that MTHFR polymorphisms are a clinical catastrophe requiring exotic treatment protocols. The most important intervention is straightforward: ensure adequate folate intake. When dietary folate is sufficient, even individuals with the TT genotype can maintain normal homocysteine levels. The use of 5-MTHF (the already-converted form of folate) rather than folic acid is sometimes recommended for individuals with MTHFR variants, though the clinical superiority of 5-MTHF over folic acid in well-nourished individuals has not been convincingly demonstrated in large trials.
Who Is at Risk for B Vitamin Deficiency
Older Adults
Age-related decline in B12 absorption is one of the most common nutritional problems of aging. Between 10 and 30 percent of adults over 50 develop atrophic gastritis — a condition in which the stomach produces less hydrochloric acid and intrinsic factor, both of which are required for B12 absorption from food. The B12 in food is protein-bound, and liberating it requires adequate stomach acid. As acid production declines, food-bound B12 absorption drops — even if dietary intake is adequate.
This is why the National Academy of Medicine recommends that adults over 50 obtain most of their B12 from supplements or fortified foods, where the vitamin is in its free (unbound) form and does not require acid-mediated liberation.
Folate absorption does not decline as markedly with age, but older adults are also more likely to have diets low in folate-rich vegetables and legumes, and elevated homocysteine is disproportionately common in this population.
Vegans and Strict Vegetarians
Because B12 is found exclusively in animal-derived foods, vegans who do not supplement are virtually guaranteed to develop B12 deficiency over time — a critical consideration explored further in our article on vegan diet and brain health. The body stores enough B12 to last roughly three to five years, so deficiency may take years to manifest — but when it does, the neurological consequences can be severe. Every major nutrition and dietetics organization, including the Academy of Nutrition and Dietetics, recommends that vegans take a B12 supplement.
Folate is generally not a concern for vegans, who typically consume abundant plant foods rich in folate. B6 is also well-represented in plant foods. But B12 is a non-negotiable supplement for anyone on a fully plant-based diet.
Metformin Users
Metformin, the most widely prescribed medication for type 2 diabetes, has been shown in multiple studies to reduce B12 absorption — likely by interfering with the calcium-dependent uptake of the B12-intrinsic factor complex in the ileum. A meta-analysis by Aroda et al. (2016) found that metformin use was associated with a 13 percent increase in the risk of B12 deficiency and a significant increase in homocysteine levels.
The American Diabetes Association recommends periodic monitoring of B12 levels in patients on long-term metformin therapy. Despite this, screening remains inconsistent in clinical practice, and many patients on metformin develop insidious B12 insufficiency that goes undetected until neurological symptoms appear.
Proton Pump Inhibitor Users
Proton pump inhibitors (PPIs) — including omeprazole, esomeprazole, lansoprazole, and pantoprazole — suppress gastric acid production and thereby impair the liberation of protein-bound B12 from food. Long-term PPI use (defined as two or more years) has been associated with a 65 percent increase in the risk of B12 deficiency in a large Kaiser Permanente cohort study (Lam et al., 2013). Given that PPIs are among the most commonly prescribed medications worldwide, and that many patients remain on them for years or decades, this represents a substantial population-level concern.
Individuals with Gastrointestinal Conditions
Conditions that impair nutrient absorption — including celiac disease, Crohn’s disease, inflammatory bowel disease, and a history of bariatric surgery — increase the risk of deficiency in multiple B vitamins. The terminal ileum, where B12 is absorbed, is frequently affected in Crohn’s disease. Bariatric surgery (particularly Roux-en-Y gastric bypass) bypasses the stomach and proximal small intestine, dramatically reducing B12 and thiamine absorption. Lifelong B vitamin monitoring and supplementation are standard of care following bariatric surgery.
Supplementation Guidance
When to Supplement
B vitamin supplementation is clearly warranted in several situations: confirmed or suspected deficiency (particularly B12), membership in a high-risk group (vegans, elderly, metformin or PPI users), and elevated homocysteine levels. For the general population eating a varied diet that includes animal products, routine B vitamin supplementation is less clearly necessary — though a basic B-complex offers cheap insurance with an excellent safety profile.
Dosage Considerations
For B12, the recommended dietary allowance (RDA) is 2.4 micrograms per day for adults, but this is the amount needed to prevent deficiency in healthy individuals with normal absorption. For older adults and those with absorption issues, effective supplemental doses are substantially higher — typically 500 to 1,000 micrograms per day — because oral absorption of crystalline B12 is only about 1 to 2 percent at high doses (via passive diffusion, bypassing the intrinsic factor system).
For folate, the RDA is 400 micrograms of dietary folate equivalents (DFE) per day for adults, rising to 600 micrograms during pregnancy. Supplemental doses in cognitive trials have typically used 400 to 800 micrograms of folic acid.
For B6, the RDA is 1.3 mg/day for adults under 50 and 1.5-1.7 mg/day for those over 50. The VITACOG trial used 20 mg/day. Unlike B12 and folate, B6 has a well-established toxicity threshold: chronic intake above 100 mg/day can cause peripheral neuropathy (ironically mimicking some symptoms of B12 deficiency). This is reversible upon discontinuation but serves as a caution against mega-dosing.
Methylated vs. Non-Methylated Forms
The debate over methylated versus non-methylated B vitamin forms has generated significant consumer confusion. The core question: should you take methylcobalamin instead of cyanocobalamin for B12, and 5-MTHF (methylfolate) instead of folic acid?
Methylcobalamin is the form of B12 that acts as a cofactor for methionine synthase. Cyanocobalamin is a synthetic form that the body must convert to methylcobalamin or adenosylcobalamin before use. Cyanocobalamin is more stable, better studied, and less expensive. It has been used in virtually all of the major clinical trials demonstrating the benefits of B12 supplementation. For the vast majority of people, cyanocobalamin is perfectly adequate. Methylcobalamin may have theoretical advantages for individuals with impaired conversion capacity, but large-scale clinical evidence demonstrating its superiority is lacking.
5-MTHF (methylfolate) bypasses the MTHFR enzyme entirely, which makes it theoretically advantageous for individuals with the MTHFR C677T TT genotype. However, folic acid — even in individuals with reduced MTHFR activity — is still converted to active folate, just at a slower rate. When folate intake is adequate, the functional difference between folic acid and 5-MTHF is minimal for most people. That said, 5-MTHF does not mask B12 deficiency the way high-dose folic acid can (by correcting anemia while neurological damage progresses unchecked), which is a genuine clinical advantage.
The pragmatic position: methylated forms are reasonable choices and may offer marginal benefits for certain genotypes, but the non-methylated forms are effective, well-tested, and substantially less expensive. Neither choice is wrong.
Practical Takeaway
Prioritize B12-rich foods if you eat animal products. Liver, clams, sardines, salmon, beef, eggs, and dairy are the best sources. Two to three servings of animal protein per day will generally meet B12 needs in individuals with normal absorption.
If you are vegan, supplement B12 without exception. Take at least 250 micrograms of cyanocobalamin daily, or 2,500 micrograms weekly. This is not optional — it is medically necessary.
Eat folate-rich foods daily. Dark leafy greens, legumes, and cruciferous vegetables are the foundation. These foods also provide fiber, polyphenols, and other nutrients with independent brain benefits.
Get your homocysteine checked. A simple blood test can reveal whether your one-carbon metabolism is functioning well. Optimal levels are below 10 micromol/L. If your homocysteine is elevated, a combination of folate, B12, and B6 supplementation is the first-line intervention.
If you are over 50, take supplemental B12. Age-related absorption decline makes food sources unreliable. The National Academy of Medicine specifically recommends that adults over 50 use supplements or fortified foods for B12.
If you take metformin or a PPI long-term, monitor B12 levels. Ask your physician for periodic testing and supplement if levels are low or borderline.
Consider a B-complex supplement as baseline insurance. A quality B-complex providing at least 100 percent of the RDA for all eight B vitamins is inexpensive, safe, and addresses the most common gaps. For targeted brain support, the VITACOG protocol (0.8 mg folic acid, 0.5 mg B12, 20 mg B6) provides a well-studied, evidence-based combination.
Do not mega-dose B6. Keep supplemental B6 below 50 mg/day unless under medical supervision. Chronic high-dose B6 can cause the very nerve damage you are trying to prevent.
Frequently Asked Questions
Can B vitamin supplementation reverse cognitive decline?
The evidence suggests that B vitamin supplementation can slow the rate of brain atrophy and cognitive decline in individuals with elevated homocysteine — but it is not a cure for established dementia. The VITACOG trial demonstrated a significant slowing of brain atrophy, and subsequent analyses showed preservation of cognitive function in the treatment group. However, these benefits were concentrated in participants with elevated homocysteine at baseline. For individuals with normal homocysteine levels, the evidence of cognitive benefit from additional B vitamin supplementation is weak.
Is it possible to get too much B12?
B12 has no established Tolerable Upper Intake Level because no adverse effects have been observed even at very high doses. The body excretes excess B12 efficiently through the kidneys. Oral doses of 1,000 micrograms or more are commonly used in clinical practice without safety concerns. That said, very high serum B12 levels that are not explained by supplementation can occasionally indicate underlying liver disease, myeloproliferative disorders, or kidney failure, and should be evaluated by a physician.
Should everyone take methylated B vitamins?
No. Methylated forms (methylcobalamin, methylfolate) are marketed as universally superior, but the evidence does not support this claim for the general population. Standard forms (cyanocobalamin, folic acid) are effective, well-studied, more stable, and less expensive. Methylated forms may offer marginal benefits for the subset of individuals with specific genetic variants (particularly MTHFR C677T homozygotes) or those with rare inborn errors of metabolism. For most people, the choice of form matters far less than the choice to ensure adequate intake.
Does folic acid fortification make folate deficiency obsolete?
Mandatory folic acid fortification of grain products — implemented in the United States in 1998 and subsequently adopted by over 80 countries — has dramatically reduced neural tube defect rates and improved population folate status. However, it has not eliminated folate insufficiency entirely. Individuals who consume few grain-based products, those with malabsorption conditions, and heavy alcohol users may still have inadequate folate levels. Furthermore, the fortification dose was calibrated to prevent neural tube defects, not necessarily to optimize homocysteine levels or cognitive function in older adults, where higher intakes may be beneficial.
How do I know if I have a B12 deficiency?
Symptoms of B12 deficiency can be subtle and nonspecific: fatigue, weakness, numbness or tingling in the hands and feet, difficulty walking, memory problems, mood changes, and a sore or swollen tongue. Because these symptoms overlap with many other conditions, diagnosis requires blood testing. Serum B12 is the standard first-line test, but it has limitations — levels in the “low normal” range (200-300 pg/mL) may already reflect functional insufficiency. Methylmalonic acid (MMA) and homocysteine are more sensitive markers: elevated MMA is highly specific for B12 deficiency, while elevated homocysteine can reflect deficiency of B12, folate, or B6.
Sources
Smith, A. D., Smith, S. M., de Jager, C. A., Whitbread, P., Johnston, C., Agacinski, G., … & Refsum, H. (2010). Homocysteine-lowering by B vitamins slows the rate of accelerated brain atrophy in mild cognitive impairment: a randomized controlled trial. PLoS ONE, 5(9), e12244.
Douaud, G., Refsum, H., de Jager, C. A., Jacoby, R., Nichols, T. E., Smith, S. M., & Smith, A. D. (2013). Preventing Alzheimer’s disease-related gray matter atrophy by B-vitamin treatment. Proceedings of the National Academy of Sciences, 110(23), 9523–9528.
Jerneren, F., Elshorbagy, A. K., Oulhaj, A., Smith, S. M., Refsum, H., & Smith, A. D. (2015). Brain atrophy in cognitively impaired elderly: the importance of long-chain omega-3 fatty acids and B vitamin status in a randomized controlled trial. The American Journal of Clinical Nutrition, 102(1), 215–221.
Seshadri, S., Beiser, A., Selhub, J., Jacques, P. F., Rosenberg, I. H., D’Agostino, R. B., … & Wolf, P. A. (2002). Plasma homocysteine as a risk factor for dementia and Alzheimer’s disease. The New England Journal of Medicine, 346(7), 476–483.
MRC Vitamin Study Research Group. (1991). Prevention of neural tube defects: results of the Medical Research Council Vitamin Study. The Lancet, 338(8760), 131–137.
Lam, J. R., Schneider, J. L., Zhao, W., & Corley, D. A. (2013). Proton pump inhibitor and histamine 2 receptor antagonist use and vitamin B12 deficiency. JAMA, 310(22), 2435–2442.
Aroda, V. R., Edelstein, S. L., Goldberg, R. B., Knowler, W. C., Marcovina, S. M., Orchard, T. J., … & Crandall, J. P. (2016). Long-term metformin use and vitamin B12 deficiency in the Diabetes Prevention Program Outcomes Study. The Journal of Clinical Endocrinology & Metabolism, 101(4), 1754–1761.
Refsum, H., Smith, A. D., Ueland, P. M., Nexo, E., Clarke, R., McPartlin, J., … & Scott, J. M. (2004). Facts and recommendations about total homocysteine determinations: an expert opinion. Clinical Chemistry, 50(1), 3–32.
Clarke, R., Bennett, D., Parish, S., Lewington, S., Skeaff, M., Eussen, S. J., … & Collins, R. (2014). Effects of homocysteine lowering with B vitamins on cognitive aging: meta-analysis of 11 trials with cognitive data on 22,000 individuals. The American Journal of Clinical Nutrition, 100(2), 657–666.
Stabler, S. P. (2013). Vitamin B12 deficiency. The New England Journal of Medicine, 368(2), 149–160.
Allen, L. H. (2009). How common is vitamin B-12 deficiency? The American Journal of Clinical Nutrition, 89(2), 693S–696S.
Kennedy, D. O. (2016). B vitamins and the brain: mechanisms, dose and efficacy — a review. Nutrients, 8(2), 68.